DPIIT recognised startup Government of India
Startup India
Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals Private Limited - chemicals in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.43 Cr
▲ 152% YoY
Net profit · FY 2024
₹10.18 Lakh
Net margin 7.1%
EBITDA · FY 2024
₹12.74 Lakh
EBITDA margin 8.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹36 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Blyners Pharmaceuticals Private Limited
Data last updated:
Blyners Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India, recognised as a startup by DPIIT. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 27 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2018PTC313085.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajendra Bhausaheb Jadhav and Yogesh Bhausaheb Jadhav.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House Number.159 A/P – Katarni Tal – Yeola, Nashik, Maharashtra, India – 423104.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.43 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.18 Lakh (net margin 7.1%) and EBITDA of ₹12.74 Lakh (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
As per MCA filings, the company has open charges of ₹36 Lakh on record.
Blyners Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0040721).
Company details
CIN U24290MH2018PTC313085
Registration Number 313085
Incorporation Date 27 August 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0040721
Key People
Rajendra Bhausaheb Jadhav Director Yogesh Bhausaheb Jadhav Director Netra Yogesh Jadhav Director Recognitions & Rankings of Blyners Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-23-0040721
Contact details
Blyners Pharmaceuticals Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressHouse Number.159 A/P – Katarni Tal – Yeola, Nashik, Maharashtra, India – 423104
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Blyners Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Blyners Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Blyners Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Blyners Pharmaceuticals Private Limited, buy the company report.
Financials of Blyners Pharmaceuticals Private Limited
FY 2025 filings availableBlyners Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 152% YoY) for FY 2024.
Revenue · FY 2024
₹1.43 Cr ▲ 152%
Net profit · FY 2024
₹10.18 Lakh margin 7.1%
EBITDA · FY 2024
₹12.74 Lakh margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 152%
3 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 285%
3 years · compounded
▲ 39%
5 years · compounded
▲ 98%
Revenue has grown at a compounded annual rate (CAGR) of 33% over three years, including 152% growth in the latest year. EBITDA rose 285% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blyners Pharmaceuticals Private Limited, buy the company report.
Board of directors of Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Bhausaheb Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
| Yogesh Bhausaheb Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
| Netra Yogesh Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
Charges & borrowings
Open charges
₹36 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2022 | 100609258 | Axis Bank Limited | ₹36 Lakh | Open |
To see the full charge records of Blyners Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Blyners Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blyners Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Blyners Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Blyners Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Netra Yogesh Jadhav was appointed as Director on 27 Aug 2018.
AGM
Blyners Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 36.00 Lakh registered on 24 Aug 2022 with Charge ID 100609258 was modified on 14 May 2025.
Filing
Blyners Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.00 Lakh with Charge ID 100609258 was registered on 24 Aug 2022.
Appointed
Netra Yogesh Jadhav was appointed as Director.
Appointed
Rajendra Bhausaheb Jadhav was appointed as Director.
Appointed
Yogesh Bhausaheb Jadhav was appointed as Director.
Incorporation
27 Aug 2018
Blyners Pharmaceuticals Private Limited was registered on 27 Aug 2018 with Roc Mumbai & aged 8 years 1 month as per MCA records.
Frequently asked questions
Blyners Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 27 August 2018 (8+ years old) and is registered under CIN U24290MH2018PTC313085.
Blyners Pharmaceuticals has 3 current directors:
- Rajendra Bhausaheb Jadhav - Director
- Yogesh Bhausaheb Jadhav - Director
- Netra Yogesh Jadhav - Director
The latest financial statements of Blyners Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Blyners Pharmaceuticals is U24290MH2018PTC313085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blyners Pharmaceuticals was incorporated on 27 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Netra Yogesh Jadhav was appointed as Director on 27 Aug 2018. Rajendra Bhausaheb Jadhav was appointed as Director on 27 Aug 2018. Yogesh Bhausaheb Jadhav was appointed as Director on 27 Aug 2018.
Yes, Blyners Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Blyners Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0040721).
The registered office of Blyners Pharmaceuticals is at House Number.159 AP – Katarni Tal – Yeola, Nashik, Maharashtra, India – 423104.
Blyners Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.